Stereotactic Body Radiation Therapy (SBRT) Plus Immune Checkpoint Inhibitors (ICI) in Hepatocellular Carcinoma and Cholangiocarcinoma.

MLA

Jiang, Joanna, et al. “Stereotactic Body Radiation Therapy (SBRT) Plus Immune Checkpoint Inhibitors (ICI) in Hepatocellular Carcinoma and Cholangiocarcinoma.” Cancers, vol. 15, no. 1, Jan. 2023, p. 50. EBSCOhost, https://doi.org/10.3390/cancers15010050.

APA

Jiang, J., Diaz, D. A., Nuguru, S. P., Mittra, A., & Manne, A. (2023). Stereotactic Body Radiation Therapy (SBRT) Plus Immune Checkpoint Inhibitors (ICI) in Hepatocellular Carcinoma and Cholangiocarcinoma. Cancers, 15(1), 50. https://doi.org/10.3390/cancers15010050

Chicago

Jiang, Joanna, Dayssy Alexandra Diaz, Surya Pratik Nuguru, Arjun Mittra, and Ashish Manne. 2023. “Stereotactic Body Radiation Therapy (SBRT) Plus Immune Checkpoint Inhibitors (ICI) in Hepatocellular Carcinoma and Cholangiocarcinoma.” Cancers 15 (1): 50. doi:10.3390/cancers15010050.